
Sign up to save your podcasts
Or


Pepsi’s 3rd quarter was strong thanks to Frito-Lay. TD Ameritrade rises on reports it may buy out rival Scottrade. And Medtronic gets FDA approval for an artificial pancreas. Plus we dip into the Fool Mailbag with Bill Mann and Bryan Hinmon from Motley Fool Funds. Thanks to Pearl Auto for supporting this episode. Go to http://PearlAuto.com/Fool to get free 2-day shipping!
By The Motley Fool4.7
16041,604 ratings
Pepsi’s 3rd quarter was strong thanks to Frito-Lay. TD Ameritrade rises on reports it may buy out rival Scottrade. And Medtronic gets FDA approval for an artificial pancreas. Plus we dip into the Fool Mailbag with Bill Mann and Bryan Hinmon from Motley Fool Funds. Thanks to Pearl Auto for supporting this episode. Go to http://PearlAuto.com/Fool to get free 2-day shipping!

3,221 Listeners

1,488 Listeners

807 Listeners

948 Listeners

523 Listeners

1,166 Listeners

2,182 Listeners

825 Listeners

1,422 Listeners

1,037 Listeners

9,717 Listeners

196 Listeners

826 Listeners

87 Listeners

585 Listeners

1,036 Listeners

53 Listeners